• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Actavis plc (ACT)

    -NYSE
    297.05 Up 0.60(0.20%) Apr 17, 4:05PM EDT
    |After Hours : 297.10 Up 0.05 (0.02%) Apr 17, 7:40PM EDT
    Add to Portfolio
    Prev Close:296.45
    Open:294.30
    Bid:296.51 x 100
    Ask:297.25 x 100
    1y Target Est:342.89
    Beta:0.78
    Next Earnings Date:11-May-15ACT Earnings announcement
    Day's Range:291.74 - 297.05
    52wk Range:193.00 - 317.72
    Volume:2,839,567
    Avg Vol (3m):3,342,410
    Market Cap:79.09B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACTUp 0.20%79.09B
    MYLUp 4.46%26.42B
    NVSDown 0.82%245.76B
    TEVAUp 2.24%55.29B

    Key Statistics

    Forward P/E (1 yr):13.98
    P/S (ttm):6.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.61
    Quarterly EPS Est (Mar-15) :3.96
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc develops, manufactures, and sells generic, brand, and biosimilar pharmaceuticals. It offers over-the-counter products. The company also provides biosimilar products in women’s health, oncology, and other therapeutic categories. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback